Company attributes
Industry
Location
CEO
Legal Name
FoRx Therapeutics AG
Number of Employees (Ranges)
11 – 50
Email Address
info@forxtherapeutics.com0
Full Address
Lichtstrasse 35, 4056 Basel Switzerland0
Investors
Founded Date
January 1, 2019
Total Funding Amount (USD)
22,705,000
Latest Funding Round Date
April 22, 2020
Board of Directors
Latest Funding Type
Country
Headquarters
Other attributes
Company Operating Status
Active
Funding Round Date
April 22, 2020
FoRx Therapeutics is a biotechnology company that is developing a drug discovery platform for cancer drugs. The company is backed by a syndicate of investors that include the Novartis Venture Fund, Pfizer Ventures, M Ventures, Omega Funds and LSP Venture Capital.
FoRx Therapeutics is focused on drugging key molecular targets that are involved in the DNA Replication Stress, as a new approach in developing targeted anticancer drugs.
FoRx scientists have more than 20 years of experience in DNA replication stress and DNA Damage Response pathways. Its team comprises of scientists and advisors who have experience in biochemistry, cancer biology, cancer genomics, medicinal chemistry and small molecule drug discovery.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
